Steroid Hormone Receptor Expression in Renal Cell Carcinoma: An Immunohistochemical Analysis of 182 Tumors
- 1 February 2004
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 171 (2), 611-614
- https://doi.org/10.1097/01.ju.0000108040.14303.c2
Abstract
Purpose: Steroid hormone receptor expression has an essential role in cancer of the prostate and breast but there is only limited experience with renal cell carcinoma (RCC), especially regarding prognostic and therapeutic impact. Materials and Methods: A total of 188 cases of RCC were stained immunohistochemically for the expression of estrogen (ER), progesterone (PR) and androgen (AR) receptors using a tissue microarray technique. Nuclear steroid hormone receptor immunoreactivities were analyzed semiquantitatively with respect to associations with histological subtype, pT stage, grading and gender using Fisher's exact test. Impact on disease-free survival was analyzed using the Kaplan-Meier method. Results: Sufficient tumor tissue was present in 182 of the 188 RCCs. AR expression was found in 27 of 182 tumors (14.8%) in 24 male and 3 female patients. AR expression was significantly associated with stage pT1 compared with pT3 (p <0.0001), and grades 1 and 2 compared with grade 3 (p = 0.0005). Regarding progression-free survival, AR positive RCCs showed a significantly better prognosis than AR negative cases (log rank test, p = 0.027). No difference of AR immunoreactivity could be detected between histological subtypes. Only 2 of the 182 cases (1.1%) showed ER and PR immunoreactivity in less than 10% of tumor cell nuclei. Conclusions: While ER and PR expression was the exception, AR expression was found in almost 15% of the tumors and it was significantly associated with low stage, well or moderately differentiated tumors and a favorable outcome, decreasing with tumor growth and dedifferentiation. However, these results do not support a potential role of hormonal therapy for metastatic RCC.Keywords
This publication has 14 references indexed in Scilit:
- Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study GroupsLaboratory Investigation, 2002
- Tissue microarrays (TMAs) for high-throughput molecular pathology researchInternational Journal of Cancer, 2001
- The androgen receptor gene and its influence on the development and progression of prostate cancerThe Journal of Pathology, 2001
- Endocrine therapy in the treatment of metastatic breast cancerSeminars in Oncology, 2001
- Microarrays of bladder cancer tissue are highly representative of proliferation index and histological gradeThe Journal of Pathology, 2001
- The Value of Immunocytochemistry in Distinguishing Between Clear Cell Carcinoma of the Kidney and OvaryInternational Journal of Gynecological Pathology, 2001
- SYSTEMIC THERAPY FOR RENAL CELL CARCINOMAJournal of Urology, 2000
- Endocrine treatment in prostate cancerSeminars in Surgical Oncology, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sitesHistopathology, 1996